Sentence examples for multiple comorbidities have from inspiring English sources

Our results suggest that patients with multiple comorbidities have a considerably different clinical presentation than those with fewer comorbid conditions, which may make them less likely to receive evidence-based therapies at the time of hospital admission and, by extension, increase their risk of adverse outcomes.

In patients with diarrhea caused by C difficile multiple comorbidities have been reported in 87.5%, malignancies in 18.75%.

Those hospitalized with severe secondary diagnoses or with multiple comorbidities have a higher risk of developing complications than those who do not [ 26, 21].

The importance of coexisting diseases has been underscored by several studies showing that COPD patients with multiple comorbidities have worse prognosis [ 4, 9– 11].

In conclusion, these results show that a high prevalence of patients with COPD and multiple comorbidities have associated high resource use and costs, especially within the all-cause use category.

Despite having the highest prevalence of diabetes of any age-group, older persons and/or those with multiple comorbidities have often been excluded from randomized controlled trials of treatments and treatment targets for diabetes and its associated conditions.

The first patient with multiple comorbidities had a confirmed Salmonella Enteridis infection with an abscess in the groin, with loosening of both components.

28 The prevalence of patients without important cardiovascular comorbidities has decreased significantly, while the prevalence of patients with multiple comorbidities has increased significantly during the years under study in this population-based investigation.

2– 4 In general, and among patients with cardiovascular disease, the presence of multiple comorbidities has been associated with increased mortality, greater utilization of health care resources, and larger health care expenditures.

To date, the drug has few concerning serious long-term side effects and can be used for those patients with multiple comorbidities, who have symptomatic, recurrent atrial fibrillation.

Moreover, although pharmaceutical companies may recommend a particular starting dose for their drugs based on their clinical trials, one has to appreciate that the clinical practice scenario is different from clinical trial scenario because many elderly patients with multiple comorbidities would have been excluded from trials.